Anzeige
Mehr »
Login
Freitag, 04.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Ist das der Durchbruch für den KI-Biotech-Geheimtipp?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
165 Leser
Artikel bewerten:
(1)

ACCESSWIRE Donates to Susan G. Komen Foundation and Joins Nashville Walk for the Cure

Finanznachrichten News

RALEIGH, NC / ACCESSWIRE / October 8, 2024 / ACCESSWIRE, a newswire service standout that provides regional, national, and global news to thousands of clients worldwide is proud to announce its donation to the Susan G. Komen Foundation and its participation in the Nashville Walk for the Cure. This commitment reflects ACCESSWIRE's dedication to supporting breast cancer research, awareness, and the communities affected by this disease.

ACCESSWIRE, a leading newswire service, announces its donation to the Susan G. Komen Foundation and participation in the Nashville Walk for the Cure, supporting breast cancer research and awareness. Learn more about ACCESSWIRE's dedication to community involvement and social responsibility.

The Susan G. Komen Foundation is a leading non-profit organization committed to ending breast cancer through ground-breaking research, community health outreach, advocacy, and programs that focus on patient support. ACCESSWIRE's contribution will help fund ongoing research and provide vital resources to those affected by breast cancer.

"Our team is honored to participate in the Nashville Walk for the Cure, where we can contribute not just financially, but also by standing side by side with survivors, fighters, and supporters in our community," said Jennifer Hammers, EVP Sales and Marketing of ACCESSWIRE. "Breast cancer touches countless lives, and we are dedicated to playing our part in advancing research and awareness."

The Nashville Walk for the Cure, held on October 5, 2024, gathers thousands of participants to show their support for breast cancer awareness and research. Team ACCESSWIRE is joining the effort, taking each step in honor of those fighting breast cancer, those who have survived, and those we have lost. By coming together, we hope to raise awareness and encourage others to join the fight against breast cancer.

This donation and event participation are part of ACCESSWIRE's ongoing commitment to social responsibility and creating a positive impact in the communities it serves.

For more information about ACCESSWIRE and its community involvement, please visit www.issuerdirect.com/newsroom

About ACCESSWIRE/Issuer Direct Corporation

Issuer Direct is a leading communications company, providing solutions for both Public Relations and Investor Relations Professionals for over 16 years. Our comprehensive solutions are used by thousands of customers from emerging startups to multi-billion-dollar global brands, ensuring their most important moments are reaching the right audiences, via our industry-leading newswire, IR website solutions, events technology, and compliance solutions. For more information, please visit www.issuerdirect.com

Contact Information

Brian Balbirnie
Chief Executive Officer
brian.balbirnie@issuerdirect.com
919.481.4000

Contact Information

Jennifer Hammers
Executive Vice President of Sales and Marketing
jennifer.hammers@issuerdirect.com
919.481.4000

Brian Balbirnie
Chief Executive Officer
brian.balbirnie@issuerdirect.com
919.481.4000

SOURCE: ACCESSWIRE



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.